Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 1/2014

01.01.2014 | 2013 SSAT Plenary Presentation

A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy

verfasst von: Benjamin C. Miller, John D. Christein, Stephen W. Behrman, Jeffrey A. Drebin, Wande B. Pratt, Mark P. Callery, Charles M. Vollmer Jr.

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The Fistula Risk Score (FRS), a ten-point scale that relies on weighted influence of four variables, has been shown to effectively predict clinically relevant postoperative pancreatic fistula (CR-POPF) development and its consequences after pancreatoduodenectomy (PD). The proposed FRS demonstrated excellent predictive capacity; however, external validation of this tool would confirm its universal applicability.

Methods

From 2001 to 2012, 594 PDs with pancreatojejunostomy reconstructions were performed at three institutions. POPFs were graded by International Study Group on Pancreatic Fistula standards as grades A, B, or C. The FRS was calculated for each patient, and clinical outcomes were evaluated across four discrete risk zones as described in the original work. Receiver operator curve analysis was performed to judge model validity.

Results

One hundred forty-two patients developed any sort of POPF, of which 68 were CR-POPF (11.4 % overall; 8.9 % grade B, 2.5 % grade C). Increasing FRS scores (0–10) correlated well with CR-POPF development (p < 0.001) with a C-statistic of 0.716. When segregated by discrete FRS-risk groups, CR-POPFs occurred in low-, moderate-, and high-risk patients, 6.6, 12.9, and 28.6 % of the time, respectively (p < 0.001). Clinical outcomes including complications, length of stay, and readmission rates also increased across risk groups.

Conclusion

This multi-institutional experience confirms the Fistula Risk Score as a valid tool for predicting the development of CR-POPF after PD. Patients devoid of any risk factors did not develop a CR-POPF, and the rate of CR-POPF approximately doubles with each subsequent risk zone. The FRS is validated as a strongly predictive tool, with widespread applicability, which can be readily incorporated into common clinical practice and research analysis.
Literatur
1.
Zurück zum Zitat van Berge Henegouwen MI, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg. 1997; 185:18–24.PubMedCrossRef van Berge Henegouwen MI, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg. 1997; 185:18–24.PubMedCrossRef
2.
Zurück zum Zitat Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, Obertop H. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000; 232:786–795.PubMedCrossRef Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, Obertop H. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000; 232:786–795.PubMedCrossRef
3.
Zurück zum Zitat Bassi C, Butturini G, Molinari E, Mascetta G, Salvia R, Falconi M, Gumbs A, Pederzoli P. Pancreatic fistula rate after pancreatic resection: the importance of definitions. Dig Surg. 2004; 21:54–59.PubMedCrossRef Bassi C, Butturini G, Molinari E, Mascetta G, Salvia R, Falconi M, Gumbs A, Pederzoli P. Pancreatic fistula rate after pancreatic resection: the importance of definitions. Dig Surg. 2004; 21:54–59.PubMedCrossRef
4.
Zurück zum Zitat Hackert T, Werner J, Buchler M. Postoperative pancreatic fistula. Surgeon. 2011; 9(4):211–17PubMedCrossRef Hackert T, Werner J, Buchler M. Postoperative pancreatic fistula. Surgeon. 2011; 9(4):211–17PubMedCrossRef
5.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005; 138:8–13.PubMedCrossRef Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005; 138:8–13.PubMedCrossRef
6.
Zurück zum Zitat Pratt WB, Callery MP, Vollmer CM. Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg 2008; 32:419–428.PubMedCrossRef Pratt WB, Callery MP, Vollmer CM. Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg 2008; 32:419–428.PubMedCrossRef
7.
Zurück zum Zitat Callery MP, Pratt WB, Vollmer CM. Prevention and management of pancreatic fistula. J Gastrointest Surg 2009; 13:163–173.PubMedCrossRef Callery MP, Pratt WB, Vollmer CM. Prevention and management of pancreatic fistula. J Gastrointest Surg 2009; 13:163–173.PubMedCrossRef
8.
Zurück zum Zitat Ansorge C, Strommer L, Andren-Sandberg A, Lundell L, Herrington M K, Segersvard R. Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. British Journal of Surgery. 2012; 99:1076–1082.PubMedCrossRef Ansorge C, Strommer L, Andren-Sandberg A, Lundell L, Herrington M K, Segersvard R. Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. British Journal of Surgery. 2012; 99:1076–1082.PubMedCrossRef
9.
Zurück zum Zitat Wellner U, Kayser G, Lapshyn H, Sick O, Makewiec F, Hoppner J, Hopt U, Keck T. A simple scoring system based on clinical factors related to pancreatic texture predicts postoperative pancreatic fistula preoperatively. HPB. 2010; 12(10):696–702PubMedCentralPubMedCrossRef Wellner U, Kayser G, Lapshyn H, Sick O, Makewiec F, Hoppner J, Hopt U, Keck T. A simple scoring system based on clinical factors related to pancreatic texture predicts postoperative pancreatic fistula preoperatively. HPB. 2010; 12(10):696–702PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Muscari F, Suc B, Kirzin S, Hay J, Fourtanier G, Fingerhut A, Sastre B, Chipponi J, Fagniez P, Radovanovic A, French associations for surgical research. Risk factors for mortality and intraabdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery. 2006; 139(5):591–9PubMedCrossRef Muscari F, Suc B, Kirzin S, Hay J, Fourtanier G, Fingerhut A, Sastre B, Chipponi J, Fagniez P, Radovanovic A, French associations for surgical research. Risk factors for mortality and intraabdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery. 2006; 139(5):591–9PubMedCrossRef
11.
Zurück zum Zitat Hashimoto Y, Sclabas G, Takahashi N, Kirihara Y, Smyrk T, Huebner M, Farnell M. Dual-phase computed tomography for assessment of pancreatic fibrosis and anastomotic failure risk following pancreatoduodenectomy. JOGS. 2011; 15(12):2193–204. Hashimoto Y, Sclabas G, Takahashi N, Kirihara Y, Smyrk T, Huebner M, Farnell M. Dual-phase computed tomography for assessment of pancreatic fibrosis and anastomotic failure risk following pancreatoduodenectomy. JOGS. 2011; 15(12):2193–204.
12.
Zurück zum Zitat Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM. A prospectively validated risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013; 216:1–14.PubMedCrossRef Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM. A prospectively validated risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013; 216:1–14.PubMedCrossRef
13.
Zurück zum Zitat Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg. 2011; 213:616–626.PubMedCrossRef Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg. 2011; 213:616–626.PubMedCrossRef
14.
Zurück zum Zitat Miller B, Christein D, Behrman S, Callery M, Drebin J, Kent T, Pratt W, Lewis R, Vollmer C. Assessing the impact of fistula after pancreaticoduodenectomy using the postoperative morbidity index. HPB. 2013. doi:10.1111/hpb.12131 Miller B, Christein D, Behrman S, Callery M, Drebin J, Kent T, Pratt W, Lewis R, Vollmer C. Assessing the impact of fistula after pancreaticoduodenectomy using the postoperative morbidity index. HPB. 2013. doi:10.​1111/​hpb.​12131
16.
Zurück zum Zitat Hashimoto Y, Traverso L. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a web-based calculator to improve homogeneity of definition. Surgery. 2010; 147(4):503–15PubMedCrossRef Hashimoto Y, Traverso L. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a web-based calculator to improve homogeneity of definition. Surgery. 2010; 147(4):503–15PubMedCrossRef
17.
Zurück zum Zitat Ferrone C, Kattan M, Tomlinson J, Thayer S, Brennan M, Warshaw A. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005; 23:7529–7535PubMedCrossRef Ferrone C, Kattan M, Tomlinson J, Thayer S, Brennan M, Warshaw A. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005; 23:7529–7535PubMedCrossRef
18.
Zurück zum Zitat Brennan M, Kattan M, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004; 240(2):293–8PubMedCrossRef Brennan M, Kattan M, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004; 240(2):293–8PubMedCrossRef
19.
Zurück zum Zitat Rockhill B, Spiegelman D, Byrne C, Hunter D, Colditz G. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001; 93:358–366PubMedCrossRef Rockhill B, Spiegelman D, Byrne C, Hunter D, Colditz G. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001; 93:358–366PubMedCrossRef
20.
Zurück zum Zitat Sachs T, Pratt W, Kent T, Callery M, Vollmer C. The pancreaticojejunal stent: Friend or foe. Surgery. 2013; 153(5):651–62 Sachs T, Pratt W, Kent T, Callery M, Vollmer C. The pancreaticojejunal stent: Friend or foe. Surgery. 2013; 153(5):651–62
Metadaten
Titel
A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy
verfasst von
Benjamin C. Miller
John D. Christein
Stephen W. Behrman
Jeffrey A. Drebin
Wande B. Pratt
Mark P. Callery
Charles M. Vollmer Jr.
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 1/2014
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-013-2337-8

Weitere Artikel der Ausgabe 1/2014

Journal of Gastrointestinal Surgery 1/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.